3 Dividend Kings to Buy Now

When the market is surging like it has been over the past three years, it’s easy to forget the importance of passive income. You’re probably more focused on the amazing gains from certain growth stocks that don’t pay dividends – and, don’t get me wrong, these types of stocks are great for a portfolio.

But that’s why adding some dividend players to the mix is ​​a good idea, too. First of all, who doesn’t love extra cash? You can easily collect these payments whether the market is rising or falling—the only thing you have to do is own a dividend-paying stock. Second, these payments may increase your gains during good times and limit your losses during hard times. They can help put you on the path to wealth in the long run.

Which stocks to buy? Dividend Kings made a smart choice, as they have increased their dividend payments for at least 50 consecutive years. This shows their commitment to their dividend strategy and their ability to pay those dividends over time. With that in mind, get ready to start the new year with passive income: Here are three dividend kings to buy now.

a road with "2026" Draw on it and walk through the forest.
Image source: Getty Images.

you may know Coca Cola (NYSE:KO) The best is the namesake drink, but the company actually sells 200 brands covering a variety of beverage types – from sparkling drinks to water. As the world’s largest non-alcoholic beverage company for more than 130 years, it has had time to build a significant brand moat (fans often want just one Coke, not another) and a record of profitability.

See also  Indoor climbing becoming 'mainstream' sport

So when you buy Coca-Cola stock, you’re buying a strong company. The company is also a dividend powerhouse, having been increasing payouts for more than 60 years. Today, Coca-Cola paid a dividend of $2.04, giving it a dividend yield of 2.9%. This exceeds the dividend yield S&P 500 Index. All of this makes Coca-Cola an effortless addition to any dividend portfolio.

KO Dividend Yield Chart
KO dividend yield data provided by YCharts

Abbott Laboratories (NYSE:ABT) is a healthcare giant operating in four distinct areas of expertise: medical devices, nutrition, diagnostics and established pharmaceuticals. I like this business model because it provides investors with a certain sense of security – if one industry faces challenges, others may continue to perform and limit the negative impact on earnings.

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *